Artificial sweeteners cognition concerns, drug company payments and prescribing decisions, graphene technology Podcast Por  arte de portada

Artificial sweeteners cognition concerns, drug company payments and prescribing decisions, graphene technology

Artificial sweeteners cognition concerns, drug company payments and prescribing decisions, graphene technology

Escúchala gratis

Ver detalles del espectáculo

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about artificial sweeteners' impact on cognitive health, how drug company payments influence prescribing decisions, and the use of graphene technology to accelerate maturation of neurons.

Todavía no hay opiniones